Moving toward improved access to medicines and health technologies for cardiovascular disease

Moving toward improved access to medicines and health technologies for cardiovascular disease

The objectives of this article are to describe the interventions carried out by the Strategic Fund of the Pan American Health Organization to facilitate access to and availability of antihypertensive medicines and devices for measuring blood pressure across the Region of the Americas as part of the...

Full description

Bibliographic Details
Main Authors:	Nora Giron, Christopher Lim, Juliana Vallini, Kemel Hallar
Format:	Article
Language:	English
Published:	Pan American Health Organization 2023-06-01
Series:	Revista Panamericana de Salud Pública
Subjects:	access to essential medicines and health technologies antihypertensive agents strategic fund medicine cost
Online Access:	https://iris.paho.org/handle/10665.2/57674

Similar Items

Barriers to access to antihypertensive medicines: insights from the HEARTS initiative in latin American and Caribbean region
by: Kathiaja Miranda Souza, et al.
Published: (2024-12-01)

Laudato Si’: a bridge towards access to medicines
by: Jorge Antonio Zepeda Bermudez, et al.
Published: (2018-05-01)

Laudato Si’: a bridge towards access to medicines
by: Jorge Antonio Zepeda Bermudez, et al.
Published: (2018-05-01)

Avanzando para mejorar el acceso a los medicamentos y tecnologías sanitarias para las enfermedades cardiovasculares
by: Nora Giron, et al.
Published: (2022-09-01)

Accessibility of essential anticancer medicines for children in the Sichuan Province of China
by: Zhe Chen, et al.
Published: (2022-11-01)

Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries
by: Moizza Zia Ul Haq, et al.
Published: (2024-12-01)

Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region
by: Alison T. Mhazo, et al.
Published: (2022-11-01)

Persistence and Adherence to Cardiovascular Medicines in Australia
by: Juliana de Oliveira Costa, et al.
Published: (2023-07-01)

Decision-making on listing new medicines for public funding in New Zealand: the case of 'new' type 2 diabetes medications
by: Caroline Stretton, et al.
Published: (2022-01-01)

Improving access to medicines by popularising generics: a study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra
by: Sonam Lavtepatil, et al.
Published: (2022-05-01)

Pricing of and Access to Essential Medicines in Mongolia
by: Gereltuya Dorj
Published: (2017-06-01)

Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique
by: Neusa Jessen, et al.
Published: (2023-02-01)

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
by: Lukas Roth, et al.
Published: (2018-11-01)

Access to innovative cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2018-12-01)

Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia
by: Rediet Masresha, et al.
Published: (2024-12-01)

Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia
by: Hachalu Dugasa Deressa, et al.
Published: (2024-04-01)

Price, Availability and Affordability of Anti-Cancer Medicines in Addis Ababa, Ethiopia
by: Alemu BA, et al.
Published: (2022-12-01)

Intraosseous access as a modern method of fast ensuring the access to the cardiovascular system in conditions of emergency medicine
by: Rafał Czyż, et al.
Published: (2017-08-01)

Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project
by: Elisa Barbieri, et al.
Published: (2023-07-01)

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024-12-01)

Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines
by: Atse H. Huisman, et al.
Published: (2024-11-01)

The right to health on accessibility to medicines and health services: A comparative study of Iranian Laws and international documents
by: Shahriar Eslamitabar, et al.
Published: (2017-07-01)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
by: Ayo-Oley Baldeh, et al.
Published: (2023-01-01)

Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India : a cluster randomised controlled trial
by: Gamage, Dilan Giguruwa, et al.
Published: (2021)

Prevalence and predictors of medication nonadherence among hypertensive patients
by: Deepak Sharma, et al.
Published: (2022-01-01)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
by: Gautam Satheesh, et al.
Published: (2024-07-01)

Safety and Efficacy of Anti-Hypertensive Medications in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
by: Mohammad Alqadi
Published: (2023-12-01)

Divergences in antihypertensive therapy in special situations in nephrology
by: Marcelo Montebello Lemos, et al.

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
by: Gautam Satheesh, et al.
Published: (2024-08-01)

Challenges of Guaranteeing Access to Medicines in Mexico: Lessons from Recent Changes in Pharmaceuticals Procurement
by: Octavio Gómez-Dantés, et al.
Published: (2022-01-01)

Registration and local production of essential medicines in Uganda
by: Petra Brhlikova, et al.
Published: (2020-12-01)

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?
by: Elif Hilal Vural, et al.
Published: (2024-05-01)

The European challenges of funding orphan medicinal products
by: Márta Szegedi, et al.
Published: (2018-11-01)

Real-world effectiveness of generic antihypertensive drugs of pradhan mantri bhartiya janaushadhi kendra
by: Chandani Sheikh, et al.
Published: (2022-01-01)

Which Psychotropic Medicines are Preferred by Iranian Psychiatrists as the most Accessible Ones under Sanctions?
by: Seyed Shahab Banihashem, et al.
Published: (2022-03-01)

Availability of Access, Watch, and Reserve groups of essential antibiotics: a cross-sectional survey
by: Sunaina Rafi, et al.
Published: (2024-01-01)

Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up
by: Dragan Kalinić, et al.
Published: (2022-06-01)

How to balance valuable innovation with affordable access to medicines in Belgium?
by: Steven Simoens, et al.
Published: (2022-09-01)

The Status of Access to Medicines and Enrollment in Welfare Schemes by Rural Elderly People of Southerner Rajasthan
by: Jadhav Abhijeet Vasant, et al.
Published: (2024-09-01)

Integrated Antihypertensive and Statin Treatment Protocols for Cardiovascular Disease Prevention in Low- and Middle-Income Countries
by: Andrew E. Moran, et al.
Published: (2024-12-01)